VF
NMTR

Virtu Financial’s 9 Meters Biopharma NMTR Stock Holding History

Virtu Financial’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,430
Closed -$49K – 2394
2022
Q3 		$49K Buy
11,430
+2,331
+26% +$11.6K ﹤0.01% 1212
2022
Q2 		$47K Buy
+9,099
New +$85.7K ﹤0.01% 1141
2022
Q1 		– Sell
-5,523
Closed -$108K – 2301
2021
Q4 		$108K Buy
5,523
+4,933
+836% +$110K 0.01% 1106
2021
Q3 		$15K Sell
590
-7,846
-93% -$185K ﹤0.01% 1399
2021
Q2 		$186K Buy
8,436
+2,511
+42% +$61.6K 0.02% 1028
2021
Q1 		$139K Buy
+5,925
New +$182K 0.01% 1208
2020
Q4 		– Sell
-1,899
Closed -$31K – 1904
2020
Q3 		$31K Buy
+1,899
New +$23K 0.01% 885
2019
Q4 		$22K Buy
1,997
+1,143
+134% +$19K ﹤0.01% 1314
2019
Q3 		$18K Sell
854
-2,287
-73% -$46.2K ﹤0.01% 1302
2019
Q2 		$73K Buy
+3,141
New +$94.2K ﹤0.01% 1180
2018
Q1 		– Sell
-196
Closed -$24K – 2794
2017
Q4 		$24K Sell
196
-354
-64% -$45.4K ﹤0.01% 2198
2017
Q3 		$77K Buy
+550
New +$86K ﹤0.01% 2137

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Virtu Financial's NMTR Position: Q4 2022 in Review

Virtu Financial sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 11,430 shares — an estimated $49K sold.

Virtu Financial first reported a position in NMTR in Q3 2017 and held it in 12 quarters. The position peaked at $186K in Q2 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • Virtu Financial reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
  • Virtu Financial sold 11,430 9 Meters Biopharma shares in Q4 2022, an estimated $49K.
  • Virtu Financial first reported a position in 9 Meters Biopharma in Q3 2017 and held it in 12 quarters.
  • Virtu Financial's 9 Meters Biopharma position peaked at $186K in Q2 2021.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.